TRISOMIES & MORE (NIPT)

VERACITY is a non-invasive prenatal test that analyses cell-free DNA (cfDNA) extracted from maternal blood for prenatal screening of fetal chromosomal aneuploidies and microdeletions. VERACITY captures and counts cfDNA fragments from selected genomic regions from chromosomes of interest using targeted enrichment and next generation sequencing (NGS) with proprietary genetic and bioinformatics tools. The main features and advantages are: 
Targeted Genomic Analysis 
High Read Depth Accurate
Fetal Fraction Measurement
Fragment Size Analysis

What Can VERACITY detect?
Autosomal Aneuploidies eg.Down syndrome (Trisomy 21) ๏ Edwards syndrome (Trisomy 18) ๏ Patau syndrome (Trisomy 13)
Sex Chromosome Aneuploidies eg Turner syndrome (Monosomy X) ๏ Triple X syndrome (Trisomy X) ๏ Klinfelter syndrome (XXY) ๏ Jacobs syndrome (XYY) ๏ XXYY syndrome
Microdeletions eg. DiGeorge syndrome (22q11.2) ๏ 1p36 deletion syndrome ๏ Smith-Magenis syndrome (17p11.2) ๏ Wolf-Hirschhorn syndrome (4p16.3)

For more information, any clarifications or concerns do contact us on (+ 356) 7979 7910 or at novagia@hotmail.com